The International Gynecology Cancer Society (IGCS) presented David Gershenson, M.D., professor and past chair of Gynecologic Oncology and Reproductive Medicine, its Award for Excellence at its November meeting in Melbourne, Australia. The honor recognizes Gershenson’s advancement of scientific knowledge, specifically of rare nonepithelial ovarian cancers, his unique breadth of experience, and his collaborative and consultative efforts with experts around the world.
Gershenson, who joined MD Anderson in 1979 and served as the department’s chair from 1998 to 2012, has held leadership roles in numerous national and international organizations. He continues to conduct clinical and translational studies with colleagues at MD Anderson and beyond.
“Our understanding of the disease’s molecular biology and genetics has transformed the field and led to dramatic opportunities in personalized medicine,” says Gershenson. “Over the past decade, we’ve transitioned from treating all ovarian cancers identically to targeting specific cancer subtypes.”
Gershenson is most proud of ushering in the next generation of gynecologic oncologists to make a difference in patients’ lives.
“Our patients teach us humility, priorities and the importance of living life to the fullest. In return, it’s vital that we offer them the very best possible care,” he says.